Clinical Trial Update: Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nanoparticle-based paclitaxel to solvent-based paclitaxel as part of neoadjuvant chemotherapy in early breast cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• nanoparticle-based paclitaxel (paclitaxel nanoparticle formulation)
• solvent-based paclitaxel (paclitaxel)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II | Phase 3 | Status: COMPLETED